Skip to main content
close menu
close menu

Search UK HealthCare

Precision Medicine Symposium

Precision Medicine Symposium

Save the date for UK Markey Cancer Center's third annual Precision Medicine Symposium!

Therapeutic Advances in Hematological and Solid Tumors
Presented by the UK Markey Cancer Center
Friday, March 8, 2019 | 8:30 a.m. – 4:30 p.m.

Griffin Gate Marriott Resort & Spa
1800 Newtown Pike
Lexington, KY 40511

This symposium highlights new advances in liquid biopsies and treatment options for lymphomas. Attendees will also learn strategies for implementing germline testing and CAR T-cell programs and the latest clinical advances in hematological malignancies and GI malignancies, including hyperthermic intraperitoneal chemotherapy (HIPEC).

Oncologists, hematologists, oncology surgeons, pathologists, radiologists, oncology nurses, researchers, clinical research staff, pharmacists, genetic counselors, cancer center administrators and cancer program leaders are encouraged to attend.

  • Register

    To register for the third annual Precision Medicine Symposium, please visit the PMS CE Central homepage.

    There is no registration cost for this event.

  • Reservations

    A hotel block is reserved at the Griffin Gate Marriott at a rate of $129 per night. We encourage you to reserve your room as soon as possible. Rooms are available until filled.

    For hotel reservations, please call Marriott central reservations at 877-204-8020 and use the code PMS to secure a rate of $129 per night.

    Online reservations: book your group rate online now for Precision Medicine Symposium: Advances in Immunotherapies.

  • Objectives

    Objectives

    Upon completion of this activity, participants will be able to:

    • List new treatment options for neuroendocrine tumors
    • Outline patient specific recommendations for managing neuroendocrine tumors
    • Describe the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of GI cancers
    • Discuss the role intraarterial chemotherapy to target metastatic liver lesions
    • Explain the role of CYP2D6 genotyping in the use of tamoxifen
    • Discuss implementation strategies for common drug metabolizing agents and their use in oncology
    • Describe the place in therapy of hypomethylating agents, sorafenib, ivosidenib, and enasidenib
    • Recognize and manage adverse effects associated with these agents

    Disclosure Statement

    All planners, speakers, authors and reviewers involved with content development for continuing education activities provided by the University of Kentucky are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity.

  • Schedule

    NOTE: When using a mobile device, please use landscape view.

    Time

    Topic

    Speaker

    8:30 - 8:45 a.m.

    Welcome

    General Session I: Assessment and Treatment of Solid Tumors

    8:45 - 9:30 a.m.

    Keynote 1: Role of ETCTN in fostering cancer research in Appalachian Kentucky:  Challenges and opportunities.

    Charles Kunos, MD, PhD
    Physician
    Investigational Drug Branch, National Cancer Institute
    Washington, DC

    9:30 - 10:15 a.m.

    Precision Treatment of Neuroendocrine Tumors

    Aman Chauhan, MD
    Assistant Professor of Medicine
    University of Kentucky

    Erica L. Takimoto, DO
    Gynecologic oncologist
    Norton Cancer Institute
    Louisville, Kentucky

    10:15 - 10:30 a.m.

    Assessment And Treatment Of Solid Tumors Overview And Discussion

    Session I Speakers

    Discuss the various treatments of solid tumors and how it impacts patient care

    10:30 - 11 a.m.

    Break

     

    11 - 11:45 a.m.

    Workshop 1 (Participants pick one)

    Novel Surgical Strategies in GI Malignancies

    Michael Cavnar, MD
    Assistant Professor of Surgery
    University of Kentucky

    Joseph Kim, MD
    Chief of Surgical Oncology
    University of Kentucky

    Implementing a Germline Precision Medicine Program

    Brook Phillips, MD
    Medical Oncologist
    St. Elizabeth Healthcare
    Edgewood, KY

    Dan Flora, MD
    Medical Oncologist 
    St. Elizabeth Healthcare
    Edgewood, KY

    New Therapies for AML, Targeting FLT3 and IDH Mutations

    Reshma Ramlal, MD
    Assistant Professor of Medicine
    University of Kentucky

    Hot Topics: Gene Expression Prognostic Assays in Breast Cancer and Markers of Intratumoral Heterogeneity

    Rachel Stewart, DO, PhD
    Assistant Professor of Pathology and Laboratory Medicine
    University of Kentucky

    Therese Bocklage, MD
    Professor of Pathology and Laboratory Medicine
    University of Kentucky

    11:45 a.m. - 1:15 p.m.

    Lunch with Ongoing Clinical Trials Poster Session

     

    1:15 - 2 p.m.

    Workshop 2 (Participants pick one)

    Implementing a CAR T-Cell Therapeutic Program

    Gerhard Hildebrandt, MD, FACP
    Professor of Medicine,  
    Division Chief, Hematology and Blood Marrow Transplantation
    University of Kentucky

    Amber Lawson, PharmD
    Assistant Professor, College of Pharmacy
    University of Kentucky

    Jennifer Christian
    Division of Hematology and Blood Marrow Transplantation
    Administrative Coordinator
    UK HealthCare

    Managing Combination Immunotherapies

    John Villano, MD, PhD
    Professor of Medicine
    University of Kentucky

    Rachael Morgan, PharmD
    Hematology/Oncology Clinical Pharmacist
    UK HealthCare

    Panel: Inherited Cancer Syndromes

    Rachel C. Miller, MD
    Associate Professor of Obstetrics and Gynecology
    University of Kentucky

    Peng Wang, MD,
    Assistant Professor of Medicine
    University of Kentucky

    Justine Cooper Pickarski, MS
    Genetic Counselor Supervisor
    University of Kentucky

    Novel Advances in Next Generation Sequencing

    Shulin Zhang, MD, PhD
    Professor of Pathology and Medicine
    University of Kentucky

    Role of NGS testing in Precision Management of Hematological Malignancies

    Ranjana Arora, MD, MPH. FCAP
    Assistant Professor of Pathology and Laboratory Medicine
    Medical Director, Molecular Hematology Services
    University of Kentucky

    2 - 2:30 p.m.

    Break

     

    General Session II:  Treatment Advances in Hematological Malignancies

    2:30 - 3 p.m.

    Treatment Advances in CAR T-cells

    Hayder Saeed, MD
    Assistant Professor of Medicine
    University of Kentucky


    Jacob Hodskins, MD, MS
    Oncologist
    Owensboro Health Medical Group
    Owensboro, Kentucky

    3 - 3:45 p.m.

    Keynote 2: The Future is Finally Here: Targeted Therapy in the Treatment of Acute Myeloid Leukemia

    Eytan M. Stein, MD
    Hematologic Oncologist
    Memorial Sloan Kettering Cancer Center
    New York, NY

    3:45 - 4 p.m.

    Treatment Advances in Hematological Malignancies Overview and Discussion

    Session II Speakers

    Moderated by:

    Firas Badin, MD, Physician
    BHMG Hematology and Oncology
    Lexington, Kentucky

    4 - 4:30 p.m.

    Wrap-up

     

  • Parking and Transportation

    •    Transportation to the conference will not be provided.

    •    Complimentary on-site parking is available for all symposium attendees. There is valet parking for a daily fee of $20.

  • Continuing Education

    CE credit will be available for all physicians, pharmacists and nurses who attend the program.

    For more information regarding CE credit for the event, please visit the PMS CE Central homepage.

  • Medicine

    The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The University of Kentucky College of Medicine designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    The University of Kentucky, College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

    • ACGME competencies
    • Patient care
    • Medical knowledge
  • Nursing

    The University of Kentucky, College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

    This educational activity is offered for a maximum of 4.75 ANCC contact hours.

    The Kentucky Board of Nursing (KBN) approves The University of Kentucky College of Nursing (UKCON) as a provider as well. ANCC and KBN approval of a continuing nursing education provider does not constitute endorsement of program content nor commercial sponsors. The University of Kentucky does not approve commercial products. This educational activity is offered for a maximum of 5.1 KBN contact hours. Provider #: 3-0008-01-18-1029. In order to receive credit, participants complete CNE activity, complete the evaluation form. Certificates may be printed once the evaluation is completed.

  • Pharmacy

    ACPE accreditationThe University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    This knowledge-based activity has been assigned UANs 0022-0000-18-223-L01-P, 0022-0000-18-224-L01-P, 0022-0000-18-227-L01-P, 0022-0000-18-226-L01-P, 0022-0000-18-225-L01-P, 0022-0000-18-228-L01-P, 0022-0000-18-229-L01-P, 0022-0000-18-230-L01-P, 0022-0000-18-231-L01-P, 0022-0000-18-232-L01-P, 0022-0000-18-233-L01-P, 0022-0000-18-234-L01-P, 0022-0000-18-235-L01-P, 0022-0000-18-236-L01-P, and 0022-0000-18-237-L01-P and will award 4.75 contact hours (0.475 CEU) of continuing pharmacy education credit in states that recognize ACPE providers.

    Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes signing in at registration, attending the entire session for which credit is claimed, completing the activity evaluation and requesting credit online at conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

    Other

    UK Healthcare CECentral certifies this activity for 4.75 hours of participation.

    Acknowledgement

    In collaboration with CECentral, UK College of Nursing Continuing Education Office and University of Kentucky Markey Cancer Center.

  • Contact us

    If you have questions, require any special arrangements to attend or would like more information about the symposium, please contact Marissa Schuh at 859-218-1034 or marissa.schuh@uky.edu